Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRI Biomarkers for Uterine Fibroids Treatment Response
NCT00746031Phase 4Completed
- Sponsor
- University of Edinburgh
- Start
- Dec 2008
- Primary completion
- Sep 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of goserelin and cetrorelix in Uterine Fibroids (UF) (3 arms), sponsored by University of Edinburgh. Primary endpoint: Uterine and fibroid volume. Started Dec 2008; status: completed.
02
Drugs
goserelincetrorelix
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT00746031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00746031.